Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Link to relevant study record(s)

Reference
Endpoint:
basic toxicokinetics, other
Type of information:
other: toxicokinetic assessment
Adequacy of study:
key study
Study period:
July 2010 - August 2010
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Toxicokinetic assessment by a certified toxicologist
Objective of study:
absorption
Qualifier:
according to guideline
Guideline:
other: Guidance on information requirements and chemical safety assessment Chapter R.7c: Endpoint specific guidance
Qualifier:
according to guideline
Guideline:
other: ECB EU Technical Guidance Document on Risk Assessment, 2003
GLP compliance:
yes (incl. QA statement)
Type:
absorption
Results:
For risk assessment purposes: oral absorption 50%, inhalation absorption 100% and dermal absorption 10%

TOXICOKINETIC ASSESSMENT

The water solubility of Blown rapeseed oil is very low (< 1 mg/L). Since in general a compound needs to be dissolved before it can be taken up from the gastro-intestinal tract, it is unlikely that Blown rapeseed oil will show a high systemic exposure after oral administration. However, its highly lipophilic character (log Pow > 6) indicates that uptake by micellular solubilisation may be of particular importance. For risk assessment purposes oral absorption of Blown rapeseed oil is set at 50%. The results of the toxicity studies do not provide reasons to deviate from this proposed oral absorption factor.

Once absorbed, distribution throughout the body will be limited due to its low water solubility. Intracellular concentration is expected to be higher than extracellular concentration based on its lipophilic character. Absorbed Blown rapeseed oil might undergo conjugation. The conjugates will either be excreted via the bile (high molecular weights compounds) or the urine (low molecular weight compounds).

Due to the very low vapour pressure (< 1.33 x 10-8 Pa) and the high boiling point (reaction and/or decomposition at ≥350°C) it is not to be expected that Blown rapeseed oil will reach the nasopharyncheal region or subsequently the tracheobranchial or pulmonary region. If Blown rapeseed oil reaches the tracheobranchial region it is likely that uptake of Blown rapeseed oil by crossing the alveolar and capillary membranes will take place based on its highly lipophilic character (log Po/w > 6). However, the low water solubility of Blown rapeseed oil (< 1 mg/L) indicates that absorption from the respiratory tract will be limited. Overall, although it is unlikely that Blown rapeseed oil will be available to a high extent after inhalation via the lungs, for risk assessment purposes the inhalation absorption of Blown rapeseed oil is set at 100%.

Blown rapeseed oil being a liquid has the potential to partition from the stratum corneum into the epidermis. However, the highly lipophilic character (log Po/w > 6) and the low water solubility (< 1 mg/L) of the substance indicate that the transfer between the stratum corneum and the epidermis will be impaired. Although the data are insufficient (no molecular weight available) to meet the criteria for 10% dermal absorption as given in the TGD, a dermal absorption of 10% is proposed for risk assessment purposes based on the available information. The results of the toxicity studies do not provide reasons to deviate from this proposed dermal absorption factor.

Conclusions:
Interpretation of results (migrated information): other: the absorption factors for risk assessment purposes have been set by a certified toxicologist: oral absorption 50%, inhalation absorption 100% and dermal absorption 10%
For risk assessment purposes:
oral absorption: 50%
inhalation absorption: 100%
dermal absorption: 10%

Description of key information

Short description of key information on absorption rate:

The absorption factors for risk assessment purposes have been set by a certified toxicologist: dermal absorption 10%

Key value for chemical safety assessment

Absorption rate - oral (%):
50
Absorption rate - dermal (%):
10
Absorption rate - inhalation (%):
100

Additional information

The absorption factors for risk assessment purposes have been set by a certified toxicologist: oral absorption 50%, inhalation absorption 100% and dermal absorption 10%.

Once absorbed, distribution throughout the body will be limited due to its low water solubility. Intracellular concentration is expected to be higher than extracellular concentration based on its lipophilic character. Absorbed Blown rapeseed oil might undergo conjugation. The conjugates will either be excreted via the bile (high molecular weights compounds) or the urine (low molecular weight compounds).

Discussion on absorption rate:

Blown rapeseed oil being a liquid has the potential to partition from the stratum corneum into the epidermis. However, the highly lipophilic character (log Po/w > 6) and the low water solubility (< 1 mg/L) of the substance indicate that the transfer between the stratum corneum and the epidermis will be impaired. Although the data are insufficient (no molecular weight available) to meet the criteria for 10% dermal absorption as given in the TGD, a dermal absorption of 10% is proposed for risk assessment purposes based on the available information.